Community Network-driven COVID-19 Testing and Vaccination of Vulnerable Populations in the Central US

Summary

This C3 project, Community network-driven COVID-19 testing of vulnerable populations in the Central US, will implement and evaluate a COVID-19 testing and vaccination approach that combines an evidence-based Social Network Testing Strategy (SNS) with community developed COVID-19 public health messages (SNS+). C3 will engage two disenfranchised populations across rural and urban sites in states across the Central US (Texas (TX), Louisiana (LA), Arkansas (AR), Indiana (IN), Illinois (IL)). C3 leverages NIDA's Justice Community Opioid Innovation Network (JCOIN), the PIs' extensive community located COVID-19 testing programs, and a network of established community partnerships. The collaborative community-academic partnerships, research and engagement infrastructure, and team's leadership across JCOIN will ensure that C3 can rapidly recruit, enroll and test most disenfranchised community members, (n=2400) and through this process, accelerate any forthcoming COVID-19 public health prevention interventions. C3 focuses on two communities most impacted by COVID-19: 1) Criminal justice involved (CJI) - non-incarcerated people with previous history of arrest/jail/prison, probation/parole, drug-court attendance, witnessed or experienced a negative interaction with police or law enforcement; and 2) Low-income Latinx - community members at 250% or below Federal Poverty Level. Both of these diverse populations, and the overlap between them, have some of the highest rates of COVID-19 infection and death in the United States. Messaging that affirms individual agency and corrects misinformation, combined with accessible and acceptable testing, is required to accelerate COVID-19 prevention for these populations.Using a two-arm randomized controlled trial design, participants will be enrolled into the Social Network testing Strategy (SNS) arm (involves social networking referrals only) or the Social Network testing Strategy with COVID-19 prevention messages (SNS+) messaging arm. The latter includes affirmation/misinformation correction messaging (discussion tools and coaching). SNS and SNS+messaging arms will both include an initial group of index study participants who will refer their network members into the study and the process will repeat itself one more time for a total of 3 waves. Indexes will refer network members (1st degree) and then those network members will refer one more round (2nd degree).

Conditions

• Covid19

Interventions

OTHER

Social Network Strategy + COVID-19 messaging

Contextually adapted and theory-driven messages - misinformation correction and self-affirmation - to increase awareness, self-efficacy and community engagement in our adapted Social Network testing Strategy (SNS). SNS is an evidence-based testing intervention that has been widely used in multiple settings with marginalized individuals (ie substance-users) who facilitate the recruitment of their social contacts into testing services.

Sponsors & Collaborators

• Howard Brown Health Center

  collaborator OTHER

• Community Action Place, Inc.

  collaborator OTHER

• Indiana University

  collaborator OTHER

• University of Arkansas

  collaborator OTHER

• Better Community Development, Inc.

  collaborator INDUSTRY

• Capitol Area Reentry Program Inc.

  collaborator INDUSTRY

• University of Texas Southwestern Medical Center

  collaborator OTHER

• San Jose State University

  collaborator OTHER

• George Mason University

  collaborator OTHER

• NORC at the University of Chicago

  collaborator OTHER

• Northwestern University

  collaborator OTHER

• Project Vida

  collaborator OTHER

• National Institute on Drug Abuse (NIDA)

  collaborator NIH

• University of Chicago

  lead OTHER

Principal Investigators

• John Schneider, MD · University of Chicago

Study Design

Allocation

RANDOMIZED

Purpose

PREVENTION

Masking

NONE

Model

PARALLEL

Eligibility

Min Age

15 Years

Sex

ALL

Healthy Volunteers

Yes

Timeline & Regulatory

Start

2021-04-29

Primary Completion

2022-12-31

Completion

2022-12-31

Countries

• United States

Study Locations